Latest News about DMTK
Recent news which mentions DMTK
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
February 27, 2021
From Benzinga
How to find the most promising SPACs and dodge the hidden dangers
February 26, 2021
From MarketWatch
3 Unstoppable Growth Stocks to Buy Right Now
February 26, 2021
From Motley Fool
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
From Benzinga
80 Biggest Movers From Friday
February 22, 2021
From Benzinga
It's Already Doubled in 2021, and This Healthcare Juggernaut Is Just Getting Started
February 20, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
3 Top Small-Cap Stocks to Buy Right Now
February 17, 2021
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 16, 2021
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
February 11, 2021
From Benzinga
Dermtech Rallies To Record High On Health Insurance Contract For Skin Cancer Detection Test
February 11, 2021
Tickers
DMTK
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 11, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
3 Unstoppable Stocks That'll Crush GameStop in 2021
February 07, 2021
From Motley Fool
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
Got $2,000? Here Are 3 Top Growth Stocks to Buy in February
February 03, 2021
From Motley Fool
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 22, 2021
January 22, 2021
From Benzinga
From Benzinga
These 3 Under-the-Radar Stocks Are Great Buys Right Now
January 18, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.